Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 22, 2008Alimentary Pharmacology & TherapeuticsOpen Access

Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab‐treated and naïve patients

View Full Paper
Ask AI
Bookmark
Share

Authors

ASArun SwaminathLenox Hill HospitalTUThomas UllmanMontefiore Medical CenterMRMichael RosenHarvard University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Swaminath et al. (2008) studied this question.

synapsesocial.com/papers/6aaba789a3cb0fae0ac07936https://doi.org/10.1111/j.1365-2036.2008.03878.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Natalizumab Induction and Maintenance Therapy for Crohn's Disease2005 · 929 citations
  2. 2Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.1994 · 622 citations
  3. 3Tacrolimus Is Safe and Effective in Patients with Severe Steroid-Refractory or Steroid-Dependent Inflammatory Bowel Disease-A Long-Term Follow-Up2006 · 184 citations